# Fount

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fount

- Industry: Healthcare
- Headquarters: Culver City, US
- Website: www.fount.bio
- Total disclosed funding: $12M
- Latest round: Series A (Mar 15, 2023)
- Investors on record: 5

## About

Founded in 2019 by its CEO, Andrew Herr, and based in California, US, Kitt Bio, Inc., doing business as Fount, operates as a fitness and wellness platform that engages in physical and mental health awareness. In March 2023, Fount raised USD 12 million in a series A funding led by investor Amity Ventures, with participation from other investors Allen & Company, Champion Hill Ventures, Elysian Park Ventures, and Not Boring Capital.

The company offers healthcare technology solutions that include systems with capsules, and soft gels, to prevent jet lag, low energy, sluggishness, brain fog, restlessness, constipation, and joint pain. The company also provides consultation services for people suffering from obesity, diabetes, stroke, and heart attack to optimize their health.

The company generates revenue through its various packs, which vary as follows: Sprint (USD 2,999), and Pro (USD 11,999).

The company plans to use the March 2023 funding for business expansion and to broaden its platform offerings.

## Funding rounds

- Series A, Mar 15, 2023, $12M — Allen & Company, Elysian Park Ventures, Amity Ventures, Not Boring Capital, Champion Hill Ventures

## Investors

- Allen & Company — Series A
- Elysian Park Ventures (https://capitalatlas.ai/funds/elysian-park-ventures) — Series A
- Amity Ventures (https://capitalatlas.ai/funds/amity-ventures) — Series A
- Not Boring Capital (https://capitalatlas.ai/funds/not-boring-capital) — Series A
- Champion Hill Ventures (https://capitalatlas.ai/funds/champion-hill-ventures) — Series A